The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Facility

4•••• I•• first lien term loan

first lienheld todayPharmaceuticals, Biotechnology & Life Sciences
Principal held
at least $19.9M
sum of BDC pieces, a lower bound
Fair value
$24.3M
107c on cost
Unfunded
Not disclosed
pieces' unfunded commitments
Pricing
SOFR+925 bp
floor 0.13%
PIK
none stated
Maturity
Dec 31, 2027
tagged by the filer
Lenders
1 holding
0 exited · 0 named on a deal
On the tape
1 quarters
Jun 30, 2026 to Jun 30, 2026
Lender group
every BDC that holds or held a piece; each row is that lender's own figures
LenderStatusPrincipalFair valueSpreadHeld
R••••• G••••• F•••••• C••••
R••••• G••••• C•••••• L••
held$19.9M$24.3M
107c
925 bpJun 30, 2026 to Jun 30, 2026
Facility through time
pieces summed per quarter end across the BDCs holding it
Quarter endBDCsPrincipal heldOn costSpreadPIKMaturity
Jun 30, 20261$19.9M107c925 bpDec 31, 2027
What changed on this facility
position and facility grain, including routine
Order
Other pieces of this borrower's structure
How this facility is known
Grain
4•••• I•• x first lien term loanderivedborrower group x kind x lien; tranches with different maturities sit under it
Size
lower bound: sum of BDC piecesderived
Status
performingsignalnon-accrual, default and restructuring are not on this tape and are never inferred from a mark
Origin
bdc tapereported